Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 8.359M
March 31, 2026 1.577M
December 31, 2025 -1.041M
September 30, 2025 1.926M
June 30, 2025 -0.04M
March 31, 2025 -0.215M
December 31, 2024 1.632M
September 30, 2024 1.214M
June 30, 2024 -0.064M
March 31, 2024 0.929M
December 31, 2023 0.294M
September 30, 2023 0.088M
June 30, 2023 -0.001M
March 31, 2023 -0.002M
December 31, 2022 -0.15M
September 30, 2022 -1.479M
Date Value
June 30, 2022 0.00
March 31, 2022 -2.033M
December 31, 2021 13.17M
September 30, 2021 1.519M
June 30, 2021 0.00
March 31, 2021 1.65M
December 31, 2020 0.458M
September 30, 2020 0.398M
June 30, 2020 0.408M
March 31, 2020 0.62M
December 31, 2019 0.56M
September 30, 2019 0.17M
June 30, 2019 0.789M
March 31, 2019 0.556M
December 31, 2018 -0.267M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. -325.19M
Neogen Corp. -0.30M
QuidelOrtho Corp. 200.60M
Aspira Women's Health, Inc. 1.293M
Biomerica, Inc. 0.871M